Cellosaurus cell line GEN2.2 (CVCL

Cellosaurus GEN2.2 (CVCL_5G44)

Cross-references
Cell line name	GEN2.2
Synonyms	Gen2.2; GEN 2.2; Gen 2.2; HLA-A*0201+ pDC line
Accession	CVCL_5G44
Resource Identification Initiative	To cite this cell line use: GEN2.2 (RRID:CVCL_5G44)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2938. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
Disease	Blastic plasmacytoid dendritic cell neoplasm (NCIt: C7203)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual	CVCL_5G45 ! GEN3
Sex of cell	Male
Age at sampling	74Y
Category	Cancer cell line
Web pages	Info; -; -; https://web.archive.org/web/20160706131224/http://www.clg.niigata-u.ac.jp:80/~matak/eng/resmat12.pdf
Publications	PubMed=16365416; DOI=10.4049/jimmunol.176.1.248 Chaperot L., Blum A., Manches O., Lui G., Angel J., Molens J.-P., Plumas J. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176:248-255(2006) Patent=US7341870 Plumas J., Chaperot L. Dendritic cell line. Patent number US7341870, 11-Mar-2008 PubMed=22696054; DOI=10.1038/jid.2012.152 Aspord C., Leccia M.-T., Salameire D., Laurin D., Chaperot L., Charles J., Plumas J. HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients. J. Invest. Dermatol. 132:2395-2406(2012)
Encyclopedic resources	Wikidata; Q54835560
Entry history
Entry creation	14-Dec-2015
Last entry update	10-Apr-2025
Version number	9